United States Files False Claims Act Complaint Alleging Genetic Testing Medicare Fraud
MIAMI – The United States has filed a complaint under the False Claims Act against AIMA Business and Medical Support, LLC (AIMA), a company that provides medical billing and compliance services, for allegedly submitting or causing the submission of false claims to Medicare for medically unnecessary genetic laboratory tests.
Action Details
- Date:June 3, 2025
- Agency:U.S. Attorney's Office, Southern District of Florida
-
Enforcement Types:
- Criminal and Civil Actions